Status:

COMPLETED

Effect of Raltegravir on Endothelial Function in HIV-Infected Patients

Lead Sponsor:

University of California, San Francisco

Collaborating Sponsors:

National Heart, Lung, and Blood Institute (NHLBI)

Merck Sharp & Dohme LLC

Conditions:

HIV Infection

Inflammation

Eligibility:

All Genders

18+ years

Phase:

PHASE4

Brief Summary

Recent studies suggest that HIV patients are at increased risk for cardiovascular events; however, the mechanisms underlying this increased risk remain unclear. Our group was one of the first to demon...

Eligibility Criteria

Inclusion

  • Stable antiretroviral therapy for at least 12 months
  • All plasma HIV RNA levels within the past year must be below level of detection (\< 50 copies RNA/mL), although isolated single values \> 50 but \< 200 copies will be allowed.
  • Screening plasma HIV RNA levels \< 50 copies RNA/mL
  • \>90% adherence to therapy within the preceding 30 days, as determined by self-report
  • Females of childbearing potential must have a negative serum pregnancy test at screening and agree to use a double-barrier method of contraception throughout the study period.
  • CD4\<350 cells/mm3 for at least one year ("immunologic non-responder") or CD4\>=350 cells/mm3 for at least one year ("immunologic responder").

Exclusion

  • Ongoing or prior use of any integrase inhibitor or R5 inhibitor.
  • Patients who plan to modify existing antiretroviral therapy in the next 24 weeks for any reason
  • Serious illness requiring hospitalization or parental antibiotics within preceding 3 months
  • Concurrent or recent exposure to any immunomodulatory drugs
  • Advanced liver disease or active hepatitis B or C
  • Patients with systolic blood pressure \<100/70
  • Starting or stopping statin therapy during the trial

Key Trial Info

Start Date :

January 1 2009

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

February 1 2014

Estimated Enrollment :

56 Patients enrolled

Trial Details

Trial ID

NCT00843713

Start Date

January 1 2009

End Date

February 1 2014

Last Update

December 12 2018

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of California, San Francisco

San Francisco, California, United States, 94110